For research use only. Not for therapeutic Use.
Ulinastatin(Cat No.:M014518)is a glycoprotein protease inhibitor derived from human urine, widely used in clinical settings to manage acute inflammatory conditions. It inhibits various proteolytic enzymes, including trypsin, chymotrypsin, and elastase, thereby reducing inflammation and tissue damage. Ulinastatin is particularly effective in treating acute pancreatitis, sepsis, and acute respiratory distress syndrome (ARDS). Modulating the inflammatory response helps in minimizing organ damage and improving patient outcomes. Its broad-spectrum inhibitory activity and safety profile make lovastatin a valuable therapeutic agent in critical care and emergency medicine.
Catalog Number | M014518 |
CAS Number | 80449-31-6 |
Synonyms | URINASTATIN (UTI) SYN. BIKUNIN;D05183;Miraclid;Miraclid (tn);Ulinastatin (jp15) |
Molecular Formula | C13H16O3 |
Purity | ≥95% |
Storage | -20°C |